BoltzGen
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 1
- Anthropic’s biomedicine strategy targets closed-loop drug discovery
A 36Kr review examines Anthropic’s biomedicine push, including Claude Science, the Model Hardware Standard for laboratory equipment, protein-design agents, wet-lab partnerships, and the Mithril and Coefficient Bio acquisitions. The review says Anthropic is using Claude to orchestrate molecular-design models such as BoltzGen and is building a “pipeline-in-a-person,” while wet-lab validation remains a constraint. It characterizes biomedicine as Anthropic’s next concentrated investment focus after coding and says the strategy is more focused than OpenAI’s broader life-science activities, though that comparison is editorial judgment.
36氪 人工智能 · 🔥 0
Experience and discussion from the community
Share my BoltzGen experienceAsk about BoltzGen
Nobody has shared their experience with BoltzGen yet.